Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omiganan and Imiquimod in Healthy Volunteers
NCT03071679Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Feb 2017
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of omiganan in psoriasis (5 arms), sponsored by Maruho Co., Ltd. Primary endpoints: Clinical Evaluation at 6 days, Pharmacodynamic Biomarkers at 2 weeks and 7 more. Started Feb 2017; status: completed.
02
Drugs
omiganan
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT03071679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03071679.